CPC C12N 15/1138 (2013.01) [A61K 31/713 (2013.01); A61P 9/00 (2018.01); A61P 27/02 (2018.01); C12N 2310/14 (2013.01)] | 18 Claims |
1. A method for reducing neovascularization in an ocular tissue, comprising contacting said ocular tissue with an inhibitor of endomucin (EMCN) expression or activity, wherein said inhibitor comprises an EMCN-specific antibody or fragment thereof.
|